At a glance
ClinicalIndex Comparison RecordN/ACompleted· 59 enrolled
Drug / intervention
HeraBEAT™ +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility and Acceptability of a Medical Grade, Smartphone-based, Fetal Heart Rate Monitor for Outpatient Use: the HeraBEAT™ Clinical Trial
In Brief
A clinical study evaluating HeraBEAT™ and Doppler fetal heart rate monitor for Pregnancy Related. Completed, enrolled 59 participants across 1 site.
Detailed Summary
Researchers are assessing the ease of use and accuracy of the HeraBEAT™ device, a new device used with a smartphone to monitor fetal heart rate during pregnancy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy Related
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartFeb 2021
Primary CompletionFeb 2022
Study CompletionAug 2022
TodayJul 2026
First PostedJan 18, 2020
Enrollment StartFeb 3, 2021
Primary CompletionFeb 28, 2022
Study CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.5 years ago
Interventions
HeraBEAT™device
A wireless Smart Fetal Ultrasound Doppler measuring device designed to be self-administered by the expectant mother throughout the different stages of pregnancy
Doppler fetal heart rate monitordevice
A hand-held ultrasound transducer that uses the Doppler Effect to provide an audible simulation of the heart beat and displays the number of beats per minute.